The novel β-blocker, carvedilol, provides neuroprotection in transient focal stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 20, Issue 8, 2000, Pages 1197-1204

  Savitz, Sean I ^a   Erhardt, Joseph A ^b   Anthony, James V ^a   Gupta, Gaurav ^a   Li, Xiang ^b   Barone, Frank C ^b   Rosenbaum, Daniel M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Apoptosis; Cerebral ischemia; Focal; Interleukin 1 ; Middle cerebral artery occlusion; Neuroprotection; Tumor necrosis factor ; blocker

Indexed keywords

CARVEDILOL; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; SCORING SYSTEM; STROKE;

EID: 0033870574     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200008000-00005     Document Type: Article

References (45)

1. Tumor necrosis factor-α: A mediator of focal ischemic brain injury
2. Inflammatory mediators and stroke: New opportunities for novel therapeutics
3. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurological examination
4. Role of oxidants in ischemic brain damage
5. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis
6. A potent antioxidant, SB209995, inhibits oxygen-radical-mediated lipid peroxidation and cytotoxicity
7. Identification of programed cell death in situ via specific labeling of nuclear DNA fragmentation
8. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system
9. The intracellular domain of p55 tumor necrosis factor receptor induces apoptosis which requires different caspases in naive and neuronal PC12 cells
10. Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells
11. Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity
12. Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions
13. Temporal profile of in situ DNA fragmentation after transient MCA occlusion in the rat
14. Evidence supporting a role for programed cell death in focal ischemia in rats
15. Oxidative stress in brain ischemia
16. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia
17. Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor
18. Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor
19. Microglia in degenerative neurological disease
20. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension
21. Potentiation of NMDA receptor currents by arachidonic acid
22. HIV-1 tat induces neuronal death via tumor necrosis factor-α and activation of non-N-methyl-D-aspartate receptors by a NF-kB-independent mechanism
23. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia vs apoptosis
24. Arachidonic acid: Toxic and trophic effects on cultured hippocampal neurons
25. Evidence of apoptotic cell death after traumatic brain injury in the rat
26. Pretreatment with intraventricular aurintricarboxylic acid decreases infarct size by inhibiting apoptosis following transient global ischemia in gerbils
27. Involvement of interleukin-1 and lipocortin-1 in ischemic brain damage
28. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure
29. Apoptosis in neurological disease
30. Gene expression after cerebral ischemia
31. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes
32. Activation of human polymorphonuclear neutrophil functions by interferongamma and tumor necrosis factor
33. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat
34. Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism
35. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA
36. Detection of tumor necrosis factor-a mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction
37. Application of real-time polymerase chain reaction to quantitate the induced expression of interleukin 1β mRNA in ischemic brain tolerance
38. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in the rats
39. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger
40. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper
41. Carvedilol, a new antihypertensive drug with unique antioxidant activity: Potential role in cerebroprotection
42. SB211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant
43. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol
44. Apoptosis: A potential target for discovering novel therapies for cardiovascular diseases
45. Reversible middle cerebral artery occlusion without craniectomy in rats